1. 301 Association of response with survival outcomes with atezolizumab in combination with vemurafenib and cobimetinib in the phase 3 IMspire150 study. (9th November 2020) Authors: Ascierto, Paolo; Lewis, Karl; Robert, Caroline; Stroyakovskiy, Daniil; Gogas, Helen; Protsenko, Svetlana; Pereira, Rodrigo; Eigentler, Thomas; Rutkowski, Piotr; Demidov, Lev; Manikhas, Georgy Moiseevich; Li, Haocheng; Zhu, Qian; McKenna, Edward; McNally, Virginia; Gutzmer, Ralf; McArthur, Grant Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A328 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 307 Atezolizumab plus vemurafenib and cobimetinib provides favorable survival outcomes in patients with high tumor mutation burden and proinflammatory gene signature in the phase 3 IMspire150 study. (10th December 2020) Authors: Lewis, Karl; Ascierto, Paolo; Robert, Caroline; Munhoz, Rodrigo; Liszkay, Gabriella; Marino, Luis De La Cruz; Olah, Judit; Queirolo, Paola; Mackiewicz, Jacek; Shah, Kalpit; Forbes, Harper; Hertig, Christian; Yan, Yibing; Gutzmer, Ralf; McArthur, Grant Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A188 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 307 Atezolizumab plus vemurafenib and cobimetinib provides favorable survival outcomes in patients with high tumor mutation burden and proinflammatory gene signature in the phase 3 IMspire150 study. (9th November 2020) Authors: Lewis, Karl; Ascierto, Paolo; Robert, Caroline; Munhoz, Rodrigo; Liszkay, Gabriella; Marino, Luis De La Cruz; Olah, Judit; Queirolo, Paola; Mackiewicz, Jacek; Shah, Kalpit; Forbes, Harper; Hertig, Christian; Yan, Yibing; Gutzmer, Ralf; McArthur, Grant Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A334 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. 548 CD8+ tissue-resident memory T cells are tumour reactive and increase after immunotherapy in a case of metastatic mucosal melanoma. (9th November 2020) Authors: Pizzolla, Angela; Keam, Simon; Vergara, Ismael; Caramia, Franco; Wang, Minyu; Kocovski, Nikolce; Nguyen, ThuNgoc; Macdonald, Sean; Tantalo, Daniela; Petrone, Pasquale; Aw Yeang, Han Xian; Gyorki, David; Weppler, Alison; Au-Yeung, George; Sandhu, Shahneen; Perdicchio, Maurizio; McArthur, Grant; Pa... Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A585 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. 548 CD8+ tissue-resident memory T cells are tumour reactive and increase after immunotherapy in a case of metastatic mucosal melanoma. (9th November 2020) Authors: Pizzolla, Angela; Keam, Simon; Vergara, Ismael; Caramia, Franco; Wang, Minyu; Kocovski, Nikolce; Nguyen, ThuNgoc; Macdonald, Sean; Tantalo, Daniela; Petrone, Pasquale; Aw Yeang, Han Xian; Gyorki, David; Weppler, Alison; Au-Yeung, George; Sandhu, Shahneen; Perdicchio, Maurizio; McArthur, Grant; Pa... Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A333 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Adverse events 2.0—Let us get SERIOs: New reporting for adverse event outcomes needed in the era of immunooncology. (May 2019) Authors: Heinzerling, Lucie; Ascierto, Paolo A.; Dummer, Reinhard; Gogas, Helen; Grob, Jean-Jacques; Lebbe, Celeste; Long, Georgina V.; McArthur, Grant; Moslehi, Javid J.; Neilan, Tomas G.; Ribas, Antoni; Robert, Caroline; Schadendorf, Dirk; Wolchok, Jedd D.; Hauschild, Axel Journal: European journal of cancer Issue: Volume 112(2019) Page Start: 29 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. An inverse stage‐shift model to estimate the excess mortality and health economic impact of delayed access to cancer services due to the COVID‐19 pandemic. Issue 4 (10th February 2021) Authors: Degeling, Koen; Baxter, Nancy N.; Emery, Jon; Jenkins, Mark A.; Franchini, Fanny; Gibbs, Peter; Mann, G. Bruce; McArthur, Grant; Solomon, Benjamin J.; IJzerman, Maarten J. Journal: Asia-Pacific journal of clinical oncology Issue: Volume 17:Issue 4(2021) Page Start: 359 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Cell cycle control as a promising target in melanoma. Issue 2 (March 2015) Authors: Lee, Belinda; Sandhu, Shahneen; McArthur, Grant Journal: Current opinion in oncology Issue: Volume 27:Issue 2(2015:Mar.) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Cell cycle control as a promising target in melanoma. Issue 2 (March 2015) Authors: Lee, Belinda; Sandhu, Shahneen; McArthur, Grant Journal: Current opinion in oncology Issue: Volume 27:Issue 2(2015:Mar.) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Chemotherapy after immune checkpoint inhibitor failure in metastatic melanoma: a retrospective multicentre analysis. (February 2022) Authors: Goldinger, Simone M.; Buder-Bakhaya, Kristina; Lo, Serigne N.; Forschner, Andrea; McKean, Meredith; Zimmer, Lisa; Khoo, Chloe; Dummer, Reinhard; Eroglu, Zeynep; Buchbinder, Elizabeth I.; Ascierto, Paolo A.; Gutzmer, Ralf; Rozeman, Elisa A.; Hoeller, Christoph; Johnson, Douglas B.; Gesierich, Anja... Journal: European journal of cancer Issue: Volume 162(2022) Page Start: 22 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗